140 related articles for article (PubMed ID: 20947677)
1. Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats.
Dumitrascu R; Kulcke C; Königshoff M; Kouri F; Yang X; Morrell N; Ghofrani HA; Weissmann N; Reiter R; Seeger W; Grimminger F; Eickelberg O; Schermuly RT; Pullamsetti SS
Eur Respir J; 2011 May; 37(5):1104-18. PubMed ID: 20947677
[TBL] [Abstract][Full Text] [Related]
2. Terguride for pulmonary arterial hypertension.
Antoniu SA
Expert Opin Ther Targets; 2011 Nov; 15(11):1333-5. PubMed ID: 21762037
[No Abstract] [Full Text] [Related]
3. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
Zhai FG; Zhang XH; Wang HL
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):850-6. PubMed ID: 19298536
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
5. Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.
Kekewska A; Görnemann T; Jantschak F; Glusa E; Pertz HH
J Pharmacol Exp Ther; 2012 Feb; 340(2):369-76. PubMed ID: 22049464
[TBL] [Abstract][Full Text] [Related]
6. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
7. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
[TBL] [Abstract][Full Text] [Related]
9. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2A receptors involved in the pulmonary artery remodeling of pulmonary artery hypertension.
Liu Y; Tian H; Yan X; Fan F; Wang W; Han J
Exp Lung Res; 2013 Mar; 39(2):70-9. PubMed ID: 23301505
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension.
Chen L; Nakano K; Kimura S; Matoba T; Iwata E; Miyagawa M; Tsujimoto H; Nagaoka K; Kishimoto J; Sunagawa K; Egashira K
Hypertension; 2011 Feb; 57(2):343-50. PubMed ID: 21220711
[TBL] [Abstract][Full Text] [Related]
11. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
Zopf DA; das Neves LA; Nikula KJ; Huang J; Senese PB; Gralinski MR
Eur J Pharmacol; 2011 Nov; 670(1):195-203. PubMed ID: 21914448
[TBL] [Abstract][Full Text] [Related]
12. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
[TBL] [Abstract][Full Text] [Related]
13. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.
Guignabert C; Raffestin B; Benferhat R; Raoul W; Zadigue P; Rideau D; Hamon M; Adnot S; Eddahibi S
Circulation; 2005 May; 111(21):2812-9. PubMed ID: 15927991
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
17. Visceral adipose tissue-derived serine protease inhibitor prevents the development of monocrotaline-induced pulmonary arterial hypertension in rats.
Sakamoto Y; Kameshima S; Kakuda C; Okamura Y; Kodama T; Okada M; Yamawaki H
Pflugers Arch; 2017 Nov; 469(11):1425-1432. PubMed ID: 28776262
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects.
Kishimoto Y; Kato T; Ito M; Azuma Y; Fukasawa Y; Ohno K; Kojima S
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):645-54.e3. PubMed ID: 26095621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
